Research, innovation and market-trend explainers — the context behind the headlines, written for people who work in the industry.
ResearchHow senolytics and microbiome modifiers are reshaping ageing biology by targeting inflammation, senescence, and system-level decline.
ResearchHow psychedelic-assisted therapies are being re-explored to treat depression, PTSD, and addiction through science-led care.
InnovationA deep dive into the clinical development, safety considerations, and commercial future of live biotherapeutic products.
ResearchHow engineered microbes are quietly reshaping API manufacturing through biology, fermentation, and smarter, more resilient pharma production.
InnovationGranulation bottlenecks rarely cause failures, but they quietly reduce throughput, inflate costs, and erode margins in pharma manufacturing.
ResearchA clear overview of GVP Module VI, explaining ICSR requirements, timelines, and EudraVigilance reporting in the EU.
ResearchHow Good Pharmacovigilance Practices are evolving from compliance into a strategic growth and trust-building function in pharma.
ResearchA strategic look at non-viral drug delivery systems, their advantages, limitations, and growing role in RNA, gene, and precision therapies.
Market TrendsA deep dive into the biggest pharma mergers of 2025 and how targeted acquisitions reshaped pipelines, innovation strategy, and long-term growth.
ResearchAI vision systems are reshaping pharma quality control by detecting contamination faster, improving consistency, and strengthening compliance.
InnovationNext-gen CAR-T cells are designed to overcome the tumor microenvironment and finally make solid tumor immunotherapy possible.
ResearchZosurabalpin is a first-in-class antibiotic targeting Gram-negative superbugs and offering new hope against antimicrobial resistance.